Ellen Koskinas focuses on life sciences investing, with an emphasis on medical devices. She is a board member of Applied Spine Technologies, Apsara Medical, CardioMind, EnteroMedics and Neuronetics. She has also been an active observer on the boards of Epicor (acquired by St. Jude Medical), NeuroPace and Paracor Medical.
Prior to InterWest, Koskinas held a number of key roles in marketing and business development at Guidant Corporation, where she built a new business in minimally invasive cardiac surgery and then led Guidant's acquisition of CardioThoracic Systems. Koskinas has also served as an Engagement Manager for McKinsey & Company, managing projects for a broad range of pharmaceutical, healthcare delivery and medical device clients. At the outset of her career, she worked in corporate finance at Morgan Stanley in New York and London.
Koskinas received a B.A. in economics with honors from Harvard College and received a M.B.A. from the Stanford Graduate School of Business.
A Word from Ellen
"Starting a new business at Guidant gave me hands-on experience in building product concepts into a growing business, and provided valuable insight into the clinical, regulatory and product development challenges of commercializing new technologies. This perspective enables me to work collaboratively with entrepreneurs and help them develop creative solutions to the inevitable bumps in the road that occur in pioneering novel therapeutic technologies."








